Faculty
Contact
- Email vinayakvmaka@msrmc.ac.in
- Phone +8040502904
Dr. Vinayak V.Maka
Professor
-
School
Medical College
-
Department
Department of Medical Oncology
Dr. Vinayak V Maka is a senior Oncologist who teaches and practices at the Ramaiah Medical College. He is familiar with diagnosing and treating all types of malignancies and carrying out autologous and allogeneic stem cell transplantations. Dr. Maka currently specializes in providing personalized cancer care in Gastrointestinal cancers, Urological cancers, Head and Neck cancers, Lung cancers, sarcoma, brain tumors and skin cancers. As Professor and Head Of Department for Medical Oncology, Dr. Maka and his team were instrumental in starting and securing approval for a sub specialty degree (DM) in medical oncology for students per year from 2016 and in starting the stem cell transplantation program in 2015. He has also been involved in various investigator instigated and industry driven clinical research and also has multiple research grants for translational oncology including rectal cancer stem cells in collaboration with Indian Institute of Science, Bangalore under RGUHS research Grant.
Qualifications
- DM Medical Oncology
B J Medical College Gujarat University, 2012
- MD General Medicine
B J Medical College Gujarat University, 2008
- MBBS
Kempegowda Institute of Medical Sciences, RGUHS University, 2004
Experience
Total Years of Experience13 Years 6 Months
Academic Experience
13 Years 6 Months
Industry Experience
13 Years 6 Months
- Selected for CReDO, an intensive oncology research protocol development workshop under TMH in 2018.
- Awarded MNAMS in Medical Oncology at the Mahatma Gandhi Medical College and Research Institute, Pondicherry in India on 26th to 28th October 2018.
- Received multiple travel grants from ESMO to attend ESMO preceptorship on various topics in Singapore (2015-2016).
- Received a travel grant from ESO to attend ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers at Milan in 2016.
- Selected to participate in the ESMO Sponsored Translational Research Unit visit at the Second University of Naples, Italy on 4-7 April 2016.
- Selected for a competitive SGHPGMI Sponsored fellowship in Hematology and BMT in Singapore General Hospital from August 2015 to February 2016.
- Awarded 1st prize of a research grant of Rs 50,000 for Best thesis presentation at 30th ICON, Ahmedabad, 4-6 April 2014.
- Successfully passed the ESMO Examination in Medical Oncology in September 2012.
- ICH GCP Trained and certified in 2013.
- Research interest focused on the "Study of Profile of Triple Negative Breast Cancer and Addition of Platinum Compound in the Treatment," presented in a dissertation at the end of the course.
- Dissertation ‘Aetiological factors in Renovascular Hypertension’ was accepted by Gujarat University for M D General Medicine in May 2008.
- Received certificate of merit for passing with distinction class in Second phase MBBS examination
National Journal Papers
- An exploration of the applicability of the refined disease risk index and its integration with other independent risk factors for individualized prognostication, 2017, Bone marrow transplantation
- Chemotherapy induced early transient febrile neutropenia despite the use of pegylated granulocyte colony stimulating factor, Global Journal For Research Analysis, 2018
- Induction Chemotherapy in Unresectable or Locally Advanced Head and Neck Squamous Cell Cancer : A Single Center Retrospective Experience, 2018, Indian Journal of Cancer Education and Research
- 5 - Fluorouracil induced extravasation injury, 2020, Indian Journal of Cancer
- Epidemiology of Adolescent and Young Adult Cancers in a Tertiary Hospital in South India, 2021, Indian Journal of Medical & paediatric oncology
International Journal Papers
- Clinical Profile, Outcome and Application of MASCC Scoring in Febrile Neutropenic Patients, 2017, Archives in Cancer Research
- The future of lung cancer therapy: Striding beyond conventional EGFR and ALK treatments, 2019, Molecular And Clinical Oncology
- Clarifications sought for implications of PORTEC-3 in clinics, 2019, Lancet Oncology
- Development of clinical hematology and stem cell transplantation program to provide state-of-the-art and cost-effective treatment to patients : a successful collaboration between medical college in India and a leading medical university in the United States, 2019, BLOOD ADVANCES
- A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2, 2020, Medical Hypotheses
- Osimertinib in EGFR-mutated advanced NSCLC, 2020, New England Journal of Medicine
- A Study Highlighting the Limited Use of Autologous Hematopoietic Stem Cell Transplant for Fit Elderly Patients with Multiple Myeloma in India, 2020
- Hypomethylating agents use in acute myeloid leukemia : A single-center experience, 2020, IJMPO
- Further clinical interpretation and implications of KEYNOTE-048 findings, 2020, The Lancet
- Clinical relevance of comprehensive genomic profiling for advanced cancers in India, 2021, Journal of Clinical Oncology
- Clinical Benefit of Comprehensive Genomic Profiling for Advanced Cancers in India, 2022, JCO Global Journal
- The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysis, 2022, Journal of the Egyptian National Cancer Institute
- Current member, ID 82241, ESMO
- Past Member, American Society of Clinical Oncology ASCO, 2013
- Lifetime member, Indian Cooperative Oncology Network (ICON), 2014
- Lifetime member, Indian Society of Medical & Pediatric Oncology (ISMPO), 2014
- Ex Hon Secretary, Association of Medical Oncologists in India (AMOI)
ADDRESS